RCW 18.64.600
Opioid use disorder medications—Remote dispensing sites—Registration—Rules—Fees.
(1) The license of location for a pharmacy licensed under this chapter may be extended to a remote dispensing site where technology is used to dispense medications approved by the United States food and drug administration for the treatment of opioid use disorder.
(2) In order for a pharmacy to use remote dispensing sites, a pharmacy must register each separate remote dispensing site with the commission.
(3) The commission shall adopt rules that establish minimum standards for remote dispensing sites registered under this section. The minimum standards shall address who may retrieve medications for opioid use disorder stored in or at a remote dispensing site pursuant to a valid prescription or chart order. The minimum standards must require the pharmacy be responsible for stocking and maintaining a perpetual inventory of the medications for opioid use disorder stored in or at the registered remote dispensing site.
(4) The secretary may adopt rules to establish a reasonable fee for obtaining and renewing a registration issued under this section.
(5) The registration issued under this section will be considered as part of the pharmacy license issued under RCW 18.64.043. If the underlying pharmacy license is not active, then the registration shall be considered inoperable by operation of law.
[ 2020 c 244 § 2.]
NOTES:
Intent—2020 c 244: "(1) The legislature declares opioid use disorder is a public health crisis. Access to medications to treat this disease needs to be made readily available, especially to vulnerable populations who may not be able to access medical care or a pharmacy.
(2) The legislature recognizes that increased access to buprenorphine, as well as additional medications necessary to aid in recovery, could benefit individuals who are suffering from opioid use disorder. The legislature further recognizes that access to pharmacies may be difficult for vulnerable populations. To increase access to medications while ensuring patient safety the legislature intends to create a new credential to allow for a pharmacy license to be extended to a remote dispensing site where technology is used to dispense medications." [ 2020 c 244 § 1.]
Structure Revised Code of Washington
Title 18 - Businesses and Professions
18.64.001 - Pharmacy quality assurance commission—Creation—Membership—Oath—Vacancies.
18.64.003 - Commission—Meetings—Chairperson—Compensation and travel expenses.
18.64.005 - Commission—Powers and duties.
18.64.006 - Commission—Panel membership—Quorum.
18.64.008 - Commission—Contraceptive availability awareness.
18.64.009 - Department of health—Enforcement employees declared to be peace officers—Authority.
18.64.020 - Licensing required.
18.64.043 - Pharmacy license—Fee—Display—Declaration of ownership and location—Penalties.
18.64.044 - Shopkeeper's registration—Penalty—Ephedrine/pseudoephedrine/phenylpropanolamine.
18.64.045 - Manufacturer's license—Fees—Display—Declaration of ownership and location—Penalties.
18.64.050 - Duplicate for lost or destroyed license or certificate—Certified documents—Fees.
18.64.140 - License—Fees—Display—Inactive license.
18.64.160 - Disciplinary action against pharmacist's and intern's licenses—Grounds.
18.64.163 - Uniform Disciplinary Act.
18.64.165 - Refusal, suspension, and revocation of other licenses.
18.64.200 - Refusal, suspension, and revocation of other licenses—Appeal procedure.
18.64.205 - Retired active license status.
18.64.245 - Prescription records—Digital or electronic form—Penalty.
18.64.246 - Prescriptions—Labels—Cover or cap to meet safety standards—Penalty.
18.64.250 - Unlawful practices—Penalty for violations—Exceptions.
18.64.253 - Students practicing pharmacy—Rules.
18.64.255 - Authorized practices.
18.64.257 - Prescription of dialysis devices and legend drugs by dialysis programs.
18.64.265 - Schedule II controlled substance—Partial fill permitted.
18.64.270 - Responsibility for drug purity—Compounding—Adulteration—Penalty.
18.64.275 - Limitations on liability for dispensing of prescription.
18.64.310 - Department of health—Powers and duties.
18.64.350 - Nonresident pharmacies—Findings.
18.64.370 - Nonresident pharmacies—License required—Application—Renewal.
18.64.380 - Nonresident pharmacies—Information required—Inspection.
18.64.390 - Nonresident pharmacies—Violations—Penalties.
18.64.400 - Nonresident pharmacies—Definition—Advertising.
18.64.410 - Nonresident pharmacies—Rules.
18.64.420 - Nonresident pharmacies—Information confidential—Exceptions.
18.64.430 - Cost disclosure to health care providers.
18.64.460 - Health care entity—License fee—Requirements—Penalty.
18.64.470 - Health care entity—Records.
18.64.480 - Waiver request to allow importation of prescription drugs from Canada.
18.64.500 - Tamper-resistant prescription pads or paper.
18.64.510 - Limitation on authority to regulate or establish standards regarding a jail.
18.64.520 - Dispensing of drug other than controlled substance—Supply limit.
18.64.530 - Topical ophthalmic products—Early refills authorized.
18.64.550 - Chart order as prescription—Long-term care facilities and hospice programs.
18.64.560 - Nursing homes and hospice programs—Emergency drug kits—Supplemental dose kits.
18.64.580 - Long-term care pharmacies—Ratio of pharmacists to pharmacy technicians—Standards.
18.64.590 - Long-term care facilities and hospice programs—Commission authority.
18.64.600 - Opioid use disorder medications—Remote dispensing sites—Registration—Rules—Fees.